Insider Stock Trader

Insider buy KTTA

Coastlands Capital LP buys $805,945 of Pasithea Therapeutics Corp. (KTTA) as a 10% owner

The 10% owner paid an average of $0.4833 a share, according to a Form 4 filed with the SEC on Nov 17.

A Form 4 filed on Nov 17 shows Coastlands Capital LP, a holder of more than 10% of Pasithea Therapeutics Corp., buying 1,667,514 shares worth $805,945 between Nov 13 and Nov 17, at about $0.4833 each.

The purchase was made in the open market, not through an award, an option exercise or a plan. The trade was reported within two business days, as Section 16 requires.

No other open-market purchase at Pasithea Therapeutics Corp. was reported in the previous 90 days. After the trade, the filing lists 5,502,549 shares held.

Figures come from the Form 4 filed with the SEC; the table lists the open-market rows this article covers.

The purchase
CompanyPasithea Therapeutics Corp. (KTTA)
InsiderCoastlands Capital LP
Role10% owner
TransactionOpen-market purchase (code P)
Shares1,667,514
Average price$0.4833
Value$805,945
Trade datesNov 13 to Nov 17, 2026
Filed with the SECNov 17, 2026, 8:42 PM ET
Shares held after5,502,549
OwnershipIndirect
Rule 10b5-1 planNot marked in the filing

See this filing row by row in Insider Stock Trader

View the Form 4 on SEC.gov

See all insider activity at Pasithea Therapeutics Corp. · See where several insiders traded together

Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.